The United Kingdom is witnessing a significant surge in interest surrounding mind-altering substances. Beyond the familiar use of psilocybin and LSD, investigators and explorers are increasingly delving into less-charted frontiers, particularly the copyright compound and the nascent cannabinoid, CBG